U.S. Biotech Breakthroughs

Zai Lab

Market Cap: US$3.0b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Scholar Rock Holding

Market Cap: US$2.6b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

GeoVax Labs

Market Cap: US$14.4m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform.

Apellis Pharmaceuticals

Market Cap: US$2.5b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Geron

Market Cap: US$885.3m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

2seventy bio

Market Cap: US$258.6m

A cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.

MDxHealth

Market Cap: US$69.8m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Organogenesis Holdings

Market Cap: US$517.5m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Natera

Market Cap: US$20.5b

A diagnostics company, provides molecular testing services worldwide.